患有高血压的个体中抗指数和视网膜血管密度之间的关系
Caterina Carollo1, Maria Vadalà2, Alessandra Sorce1
1Unit of Nephrology and Dialysis, Hypertension Excellence Centre, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90133 Palermo, Italy.
Biomedicines
|February 26, 2025
概括
患有较高抗指数 (RRI) 的高血压患者显示,深血管密度降低,夜间脉压增加. 这突显了脏健康和动脉高血压中的眼睛微循环之间的联系.
科学领域:
- 眼科和科的眼科和科.
- 心血管研究研究心血管研究
- 医疗成像医学成像
背景情况:
- 眼睛和脏之间存在生理上的相似之处.
- 动脉高血压对脏和眼睛微血管都有影响.
- 抗性指数 (RRI) 是病和全身血管功能障碍的标志物.
研究的目的:
- 为了研究视网膜血管密度和高血压患者的RRI之间的关系.
- 用光学一致性断层扫描血管学 (OCT-A) 来评估眼部微血管变化.
- 探索与血液动力学参数和功能标志物的关联.
主要方法:
- 82名高血压患者接受了OCT-A,脏多普勒超声波和血压监测.
- 进行了生物化学评估和尿路白蛋白分泌 (UAE).
- 患者根据RRI百分位数进行了分层,并进行了逻辑回归分析.
主要成果:
- 较高的RRI (>75百分位数) 与增加的甘油三,阿联和降低估计的淋巴细胞过率 (eGFR) 相相关.
- 在较高RRI组中观察到夜间脉压升高.
- 较低的深血管密度与较高的RRI显著相关.
结论:
- 眼部微血管变化,特别是减少深血管密度,与高血压患者的RRI有关.
- RRI独立地与夜间脉冲压的增加和深血管密度的降低有关.
- 研究结果支持高血压中脏和眼睛的微循环健康之间存在强烈的联系.
相关概念视频
Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Vascular Resistance
3.2K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
3.2K
Antihypertensive Drugs: Direct Renin Inhibitors
469
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
469
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
452
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
452
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54


